{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:54:13Z","timestamp":1790679253407,"version":"4.1.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T00:00:00Z","timestamp":1368748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0063506","type":"journal-article","created":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T17:14:16Z","timestamp":1368810856000},"page":"e63506","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":117,"title":["Dysregulated Autophagy Contributes to Podocyte Damage in Fabry\u2019s Disease"],"prefix":"10.1371","volume":"8","author":[{"given":"Max C.","family":"Liebau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"H\u00f6pker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Weitbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman-Ulrich","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Brodesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moin A.","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Benzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Schermer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Cybulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Kurschat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,5,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","article-title":"Fabry disease","volume":"122","author":"R Schiffmann","year":"2009","journal-title":"Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset fabry disease revealed by newborn screening","volume":"79","author":"M Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","article-title":"High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population","volume":"2","author":"HY Lin","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.2010.484","article-title":"Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease","volume":"79","author":"B Najafian","year":"2011","journal-title":"Kidney Int"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1093\/ndt\/gfp528","article-title":"Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN)","volume":"25","author":"AB Fogo","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00020.2002","article-title":"Cell biology of the glomerular podocyte","volume":"83","author":"H Pavenstadt","year":"2003","journal-title":"Physiol Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/MNH.0b013e3282f94a96","article-title":"The spectrum of focal segmental glomerulosclerosis: new insights","volume":"17","author":"VD D\u2019Agati","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e25065","DOI":"10.1371\/journal.pone.0025065","article-title":"Receptor-mediated endocytosis of \u03b1-galactosidase A in human podocytes in Fabry disease","volume":"6","author":"T Prabakaran","year":"2011","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human \u03b1-galactosidase A\u2013replacement therapy in Fabry\u2019s disease","volume":"345","author":"CM Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/S0140-6736(09)61493-8","article-title":"Enzyme replacement therapy with agalsidase alfa in patients with Fabry\u2019s disease: an analysis of registry data","volume":"374","author":"A Mehta","year":"2009","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2215\/CJN.03130411","article-title":"The effectiveness of long-term agalsidase alfa therapy in the treatment of Fabry nephropathy","volume":"7","author":"S Feriozzi","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1172\/JCI9711","article-title":"Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation","volume":"105","author":"A Abe","year":"2000","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/j.1742-4658.2006.05223.x","article-title":"Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1. Cyclosporin A can lower serum and liver globotriaosyl ceramide levels in the Fabry mouse model","volume":"273","author":"M Mattocks","year":"2006","journal-title":"FEBS J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","article-title":"A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression","volume":"13","author":"MA Saleem","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0021-9258(17)38286-8","article-title":"Purification and properties of the two major isozymes of \u03b1-galactosidase from human placenta","volume":"253","author":"JW Kusiak","year":"1978","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0005-2760(76)90245-9","article-title":"High resolution preparative column chromatographic system for gangliosides using DEAE-Sephadex and a new porus silica, Iatrobeads","volume":"441","author":"T Momoi","year":"1976","journal-title":"Biochim Biophys Acta"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0003-2697(85)90447-6","article-title":"Microanalysis of complex tissue lipids by high-performance thin-layer chromatography","volume":"150","author":"JK Yao","year":"1985","journal-title":"Anal Biochem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1172\/JCI44774","article-title":"Role of mTOR in podocyte function and diabetic nephropathy in humans and mice","volume":"121","author":"M Godel","year":"2011","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI39492","article-title":"Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice","volume":"120","author":"B Hartleben","year":"2010","journal-title":"J Clin Invest"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1172\/JCI44771","article-title":"mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice","volume":"121","author":"K Inoki","year":"2011","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1681\/ASN.2011070690","article-title":"Inhibition of MTOR Disrupts Autophagic Flux in Podocytes","volume":"23","author":"DP Cina","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"N Mizushima","year":"2011","journal-title":"Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"DJ Klionsky","year":"2012","journal-title":"Autophagy"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00467-010-1692-x","article-title":"Pathogenesis and therapy of focal segmental glomerulosclerosis: an update","volume":"26","author":"R Gbadegesin","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/01.ASN.0000016684.07368.75","article-title":"Renal pathology in Fabry disease","volume":"13","author":"J Alroy","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000187761","article-title":"Verotoxin-binding in human renal sections","volume":"66","author":"CA Lingwood","year":"1994","journal-title":"Nephron"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1523-1755.2002.00502.x","article-title":"Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model","volume":"62","author":"NW Rutjes","year":"2002","journal-title":"Kidney Int"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1432-1033.2003.03941.x","article-title":"Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody","volume":"271","author":"D Chark","year":"2004","journal-title":"Eur J Biochem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1681\/ASN.2006080822","article-title":"Distribution of \u03b1-galactosidase A in normal human kidney and renal accumulation and distribution of recombinant \u03b1-galactosidase A in Fabry mice","volume":"18","author":"EI Christensen","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1681\/ASN.2008070694","article-title":"Lipid-protein interactions along the slit diaphragm of podocytes","volume":"20","author":"B Schermer","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/01.ASN.0000130167.30769.55","article-title":"Signaling at the slit diaphragm","volume":"15","author":"T Benzing","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4161\/auto.3906","article-title":"Autophagy, mitochondria and cell death in lysosomal storage diseases","volume":"3","author":"K Kiselyov","year":"2007","journal-title":"Autophagy"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","article-title":"Common and uncommon pathogenic cascades in lysosomal storage diseases","volume":"285","author":"EB Vitner","year":"2010","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/hmg\/ddm289","article-title":"A block of autophagy in lysosomal storage disorders","volume":"17","author":"C Settembre","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Chevrier M, Brakch N, Celine L, Genty D, Ramdani Y, <etal>et al<\/etal>.. (2010) Autophagosome maturation is impaired in Fabry disease. Autophagy 6.","DOI":"10.4161\/auto.6.5.11943"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1152\/physrev.00030.2009","article-title":"Regulation of mammalian autophagy in physiology and pathophysiology","volume":"90","author":"B Ravikumar","year":"2010","journal-title":"Physiol Rev"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0063506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T05:19:52Z","timestamp":1645075192000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0063506"}},"subtitle":[],"editor":[{"given":"Christos","family":"Chatziantoniou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,17]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0063506","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,17]]}}}